Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sjoerd H. Hofma

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Interventional Cardiology Reports|February 15, 2001
Recent Developments in Coated StentsSjoerd H. Hofma, Heleen M.M. van Beusekom, Patrick W. Serruys, et al.
Interactive Cardiovascular and Thoracic Surgery|July 31, 2014
Transcatheter aortic valve implantation using a direct aortic approach: a single-centre Heart Team experienceHafid Amrane, Fabiano Porta, Ad J van Boven, et al.
Plos One|June 12, 2013
Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stentsMatthijs A Velders, Sjoerd H Hofma, Jan Brouwer, et al.
Journal of the American College of Cardiology|July 28, 2012
Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trialSjoerd H Hofma, Jan Brouwer, Matthijs A Velders, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 10, 2015
Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trialSjoerd H Hofma, Pieter C Smits, Jan Brouwer, et al.
JACC. Cardiovascular Interventions|June 6, 2017
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent)Georgios J Vlachojannis, Pieter C Smits, Sjoerd H Hofma, et al.
International Journal of Cardiology|July 5, 2017
Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trialsGiuseppe De Luca, Peter Smits, Sjoerd H Hofma, et al.
Circulation. Cardiovascular Interventions|October 1, 2024
Comparison of Ultrathin- Versus Thin-Strut Stents in Patients With High Bleeding Risk PCI: Results From the COMPARE 60/80 HBR Trial: An Open-Label, Randomized, Controlled TrialPieter C Smits, Pim A L Tonino, Sjoerd H Hofma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 22, 2015
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trialGeorgios J Vlachojannis, Pieter C Smits, Sjoerd H Hofma, et al.
European Heart Journal|October 27, 2005
Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantationSjoerd H Hofma, Wim J van der Giessen, Bas M van Dalen, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Interventional Cardiology Reports|February 15, 2001
Recent Developments in Coated StentsSjoerd H. Hofma, Heleen M.M. van Beusekom, Patrick W. Serruys, et al.
Interactive Cardiovascular and Thoracic Surgery|July 31, 2014
Transcatheter aortic valve implantation using a direct aortic approach: a single-centre Heart Team experienceHafid Amrane, Fabiano Porta, Ad J van Boven, et al.
Plos One|June 12, 2013
Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stentsMatthijs A Velders, Sjoerd H Hofma, Jan Brouwer, et al.
Journal of the American College of Cardiology|July 28, 2012
Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trialSjoerd H Hofma, Jan Brouwer, Matthijs A Velders, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 10, 2015
Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trialSjoerd H Hofma, Pieter C Smits, Jan Brouwer, et al.
JACC. Cardiovascular Interventions|June 6, 2017
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent)Georgios J Vlachojannis, Pieter C Smits, Sjoerd H Hofma, et al.
International Journal of Cardiology|July 5, 2017
Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trialsGiuseppe De Luca, Peter Smits, Sjoerd H Hofma, et al.
Circulation. Cardiovascular Interventions|October 1, 2024
Comparison of Ultrathin- Versus Thin-Strut Stents in Patients With High Bleeding Risk PCI: Results From the COMPARE 60/80 HBR Trial: An Open-Label, Randomized, Controlled TrialPieter C Smits, Pim A L Tonino, Sjoerd H Hofma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 22, 2015
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trialGeorgios J Vlachojannis, Pieter C Smits, Sjoerd H Hofma, et al.
European Heart Journal|October 27, 2005
Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantationSjoerd H Hofma, Wim J van der Giessen, Bas M van Dalen, et al.
Pageof 6